InflaRx (NasdaqGS:IFRX) Update / Briefing November 10, 2025 08:00 AM ET Speaker0Good morning, everyone. It's my pleasure to welcome you as well to our conference call this morning on our top-line phase two AE data. We're thrilled to share these data with you, and we're very happy that we got to this point. So we will dive right in. Before we do so, just two notes here: I will be joined by our Chief Medical Officer, Dr. Camilla Chong. Dr. Chong will present the data in chronic spontaneous urticaria, and I wi ...